Samuel Sears

Directeur/Membre du Conseil chez HEDGEPATH PHARMACEUTICALS INC Fortune : 109 429 $ au 31/08/2026

Profil

Mr. Samuel J.
Sears, Jr., is an Independent Director at Inhibitor Therapeutics, Inc. and an Of Counsel at Cetrulo & Capone LLP.
He is on the Board of Directors at Inhibitor Therapeutics, Inc. Mr. Sears was previously employed as an Independent Director by BioDelivery Sciences International, Inc., an Independent Director by Commonwealth Biotechnologies, Inc., a Vice Chairman by American Prescription Providers, Inc., a Chairman & Chief Executive Officer by Star Scientific, Inc., and a Managing Partner by Burns & Levinson LLP.
He also served on the board at Independent Bank Corp.
(Michigan) and The Casual Male, Inc. He received his undergraduate degree from Harvard College and a graduate degree from Boston College Law School.

Détentions connues dans des sociétés publiques

Société	Date	Nombre d'actions	Valorisation	Date de valorisation
INHIBITOR THERAPEUTICS INC. 0,71 %	17/08/2026	1 229 543 ( 0,71 % )	109 429 $	31/08/2026

Postes actifs de Samuel Sears

Sociétés	Poste	Début
HEDGEPATH PHARMACEUTICALS INC	Directeur/Membre du Conseil	13/12/2022
Cetrulo & Capone LLP	Conseiller Juridique Général	01/01/2019

Anciens postes connus de Samuel Sears

Sociétés	Poste	Fin
BIODELIVERY SCIENCES INTERNATIONAL, INC.	Directeur/Membre du Conseil	21/05/2018
HEDGEPATH PHARMACEUTICALS INC	Directeur/Membre du Conseil	30/11/2016
Commonwealth Biotechnologies, Inc.	Directeur/Membre du Conseil	19/08/2013
American Prescription Providers, Inc.	Directeur/Membre du Conseil	01/02/1999
ROCK CREEK PHARMACEUTICALS, INC.	Directeur Général	01/05/1998